Missing/wrong data?
Log in to edit
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
scientific article published on 14 March 2017
Author/s
author: Linda T Vahdat, Joyce O'Shaughnessy, Sara M Tolaney
Work details
Publication date
March 14, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.